Abstract
AbstractAwareness is growing that, besides several neurotoxic effects, cholinomimetic drugs able to interfere the cholinergic neurotransmitter system may exert a teratogen effect in developing embryos of vertebrate and invertebrate organisms. Cholinomimetic substances exert their toxic activity on organisms as they inhibit the functionality of the cholinergic system by completely or partially replacing the ACh molecule both at the level of the AChE active site and at the level of acetylcholine receptors. In this work, we focused the attention on the effects of muscarinic antagonist (atropine) and agonist (carbachol) drugs during the early development and ontogenesis of chick embryos. An unsteady-state mathematical model of the drug release and fate was developed, to synchronize exposure to a gradient of drug concentrations with the different developmental events. Since concentration measures in time and space cannot be taken without damaging the embryo itself, the diffusion model was the only way to establish at each time-step the exact concentration of drug at the different points of the embryo body (considered two-dimensional up to the 50 h stage). This concentration depends on the distance and position of the embryo with respect to the releasing source. The exposure to carbachol generally enhanced dimensions and stages of the embryos, while atropine mainly caused delay in development and small size of the embryos. Both the drugs were able to cause developmental anomalies, depending on the moment of development, in a time- and dose-dependent way, regardless the expression of genes driving each event.
Graphical abstract
Early chick embryos were exposed to muscarinic drugs in a spatial-temporal context.
Effects were stage-(time) dependent, according to distance and position of the source.
Atropine inhibited growth, mainly interfering with the cephalic process formation and heart differentiation; carbachol increased growth reducing differentiation.
Interferences may be exerted by alteration of calcium responses to naturally occurring morphogen-driven mechanisms.
Funder
Università degli Studi di Genova
Publisher
Springer Science and Business Media LLC
Subject
Health, Toxicology and Mutagenesis,Cell Biology,Toxicology
Reference48 articles.
1. Aluigi MG, Angelini C, Falugi C, Fossa R, Genever P, Gallus L, Layer PG, Prestipino G, Rakonczay Z, Sgro M, Thielecke H, Trombino S. Interaction between organophosphate compounds and cholinergic functions during development. Chem Biol Interact. 2005;157–158:305–16. https://doi.org/10.1016/j.cbi.2005.10.037.
2. Aluigi MG, Angelini C, Corte G, Falugi C. The sea urchin, Paracentrotus lividus, embryo as a “bioethical” model for neurodevelopmental toxicity testing. Cell Biol Toxicol. 2008. https://doi.org/10.1007/s10565-008-9061-2.
3. Angelini C, Costa M, Morescalchi F, Cimoli G, Coniglio L, Falugi C. Muscarinic drugs affect cholinesterase activity and development of eye structures during early chick development. Eur J Histochem. 1998;42(4):309–20.
4. Bakry NM, el-Rashidy AH, Eldefrawi AT, Eldefrawi ME. Direct actions of organophosphate anticholinesterases on nicotinic and muscarinic acetylcholine receptors. J Biochem Toxicol. 1988;3:235–59. https://doi.org/10.1002/jbt.2570030404.
5. Berridge MJ. Phosphatidyldmositol hydrolysis: A multifunctional transducing mechanism. Mol Cell Endocrinol. 1981;24(2):115–140. https://doi.org/10.1016/0303-7207(81)90055-1
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献